Background: Microsporum gypseum is a geophilic dermatophyte that colonises keratinous substances in the soil. Fur-bearing animals carry this dermatophyte but are rarely infected. Human infection can be acquired from the soil, carrier or infected animals, and rarely other humans. M gypseum is an uncommon cause of cutaneous infection in humans and typically manifests as tinea corporis, tinea barbae, and tinea capitis. Onychomycosis is rarely caused by M gypseum. Case Summary: We present a case of a 32-year-old white man who presented with a red scaly rash and nail dystrophy after adopting a pet rat 10 years prior to presentation. A fungal culture of a nail clipping grew out M gypseum, and the patient was treated with terbinafine daily for 6 weeks for dystrophic onychomycosis and tinea corporis. After the 6 weeks of treatment, the erythema at the proximal nail fold and distal finger had improved but still persisted. An additional 6 weeks of terbinafine daily completely resolved the clinical manifestations of onychomycosis. Conclusion: The increase in incidence of M gypseum onychomycosis over the past 2 decades is thought to be due to phylogenetic evolution of the dermatophyte from soil saprophyte to a human parasite. Increasing domestication of mammals is also thought to contribute to increasing incidence. Treatment consists of an extended course of terbinafine or itraconazole.
Background
Onychomycosis is a common disorder worldwide, with an incidence that varies depending upon geographical location and time. 1 It is approximated that onychomycosis accounts for 50% of all nail disorders and affects 2% to 18.5% of the world's population. 2 In Western Europe and North America, onychomycosis is predominately caused by dermatophytes, with Trichophyton rubrum and Trichophyton mentagrophytes being the most likely causative organisms. 2, 3 Onychomycosis caused by dermatophytes in the genera Microsporum is uncommon and usually due to Microsporum canis, although Microsporum gypseum has been documented as a rare cause. 4 Historically, documentation of cutaneous infection with M gypseum in humans has been rare and can occur in outbreaks. 5 A recent study in Egypt, however, found that M gypseum was the second most prevalent organism isolated in cases of tinea capitis and the third most prevalent in cases of tinea corporis, supporting the understanding that the aetiological agents involved in cutaneous fungal infections also vary with location and time. 6 Past documentation of M gypseum infections has also supported that it is more likely to cause tinea capitis and tinea corporis than it is onychomycosis.
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Case Summary
We present a case of a 32-year-old white man with no medical history who presented with a red scaly rash and nail dystrophy. These findings first manifested after adopting a pet rat 10 years prior to presentation. On examination, the patient's right fourth fingernail exhibited a tented shape and had longitudinal ridging and splinter haemorrhages. The proximal nail fold and distal finger were erythematous and the cuticle was absent (Figure 1) . A fungal culture of a nail clipping grew out M gypseum.
The patient was treated with oral terbinafine 250 mg daily for 6 weeks for dystrophic onychomycosis and tinea corporis due to M gypseum. At the 6 weeks of treatment, the erythema Case Report at the proximal nail fold and distal finger had improved but still persisted ( Figure 2 ). Thus, treatment with terbinafine 250 mg/d was continued for an additional 6 weeks, with resolution of proximal nail fold and distal finger erythema and improvement of nail dystrophy.
Conclusion
M gypseum is a geophilic dermatophyte distributed worldwide that colonises keratinous substances in the soil, such as feathers, hair, and nails. 4 It is more likely to be isolated from soil that is moist and shaded such as in gardens, parks, and residential soil. 4 M gypseum produce keratinases, conferring keratolysis as an important virulence factor for these organisms. 4 Fur-bearing animals, such as cats, dogs, and rodents, carry this organism but are rarely infected. 4 Human infection can be acquired from the soil, healthy or sick animals, and rarely other humans. 4 M gypseum is an uncommon documented cause of cutaneous infection in humans, but when it occurs, it typically manifests as tinea corporis, tinea barbae, and tinea capitis (sometimes with kerion). 5, 7 Onychomycosis is rarely caused by M gypseum.
The first case of M gypseum onychomycosis was reported in 1953, and while several additional cases have been reported since then, it remains a rare occurrence. 4 Tinea corporis due to M gypseum has also been an infrequent finding, although possibly on the rise in locations such as Egypt and Brazil. 5, 6 Many of the documented cases are found in farmers and those with exposure to soil. 4, 6, 7 When presenting as onychomycosis, M gypseum will usually present as a distal lateral subungal onychomycosis of the toenail or fingernail, although there has been a case of M gypseum proximal subungal hyperkeratosis as well as a case of total nail dystrophy reported. 4, 7 Tinea corporis due to M gypseum typically manifests as an inflammatory mycosis that tends to affect glabrous skin and may exhibit pustules, which could lead to mistreatment with topical steroids. 6 Diagnosis can be made by in vitro fungal culture of the nail sample.
1 M gypseum colonies grow rapidly and darken to a cinnamon brown color with a granular texture. Slide culture shows numerous, thin-walled ellipsoidal macroconidia (composed of 3-6 cells) with rounded tips. 4 The recommended treatment of M gypseum onychomycosis is oral terbinafine or itraconazole. 8 Treatment of M gypseum tinea corporis has been successful with topical imidazole or terbinafine for a minimum of 4 weeks but often requires oral antifungals for more extensive cutaneous involvement. 5 In vitro susceptibility testing of this organism by Krakhecke et al 9 demonstrated a low minimum inhibitory concentration (MIC) (<0.03 µg/mL) for itraconazole and terbinafine as well as a relative resistance to fluconazole (MIC of 8-64 µg/mL). More recent in vitro testing similarly revealed an increased resistance to fluconazole, while a low MIC (<0.03) was found with ketoconazole and itraconazole. 10 Resistance and crossresistance within the azole class have been described, especially in patients who are on prophylaxis for oral candidiasis. Galhardo et al 11 describe the treatment of a patient with AIDS who had widespread M gypseum that was initially responsive to itraconazole. Treatment was interrupted and resistance was discovered when the drug was reintroduced. The patient was subsequently successfully treated with oral terbinafine and topical amorolfine. The literature suggests that Microsporum infections may require a longer course of treatment than other dermatophytes, which was demonstrated in our patient's case. Optimal treatment duration has not yet been established, but 12 weeks of oral terbinafine was successful in clinically curing our case. 4 Studies support the use of laser therapy in the treatment of onychomycosis, but its use is not first line due to insufficient well-conducted clinical trials to determine true efficacy. 12 A limitation of our case study includes the absence of a follow-up culture from the affected nail after the treatment was completed. The presence of pathologic fungal organisms has been found to be present in normal-appearing nail plates. 13 Thus, while our patient was clinically cured, we are unable to confirm mycologic cure without follow-up cultures. 
Journal of Cutaneous Medicine and Surgery 22(1)
While M gypseum onychomycosis is very uncommon, cases have increasingly been reported in the literature over the past 2 decades. This increase is thought to be due to phylogenetic evolution of the dermatophyte from soil saprophyte to a human and animal parasite. 7, 8 Increasing domestication of dogs, cats, and rodents is also thought to contribute to increasing incidence, and pets continue to be the most important source of zoophilic M gypseum. 4, 7 Although onychomycosis due to M gypseum is rare, it should be considered a plausible causative organism, especially in individuals with known contact to soil or fur-bearing animals in close contact with soil. 4 
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